Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Ra Pharmaceuticals, Inc. | a2240828z10-k.htm |
| EX-31.2 - EX-31.2 - Ra Pharmaceuticals, Inc. | a2240828zex-31_2.htm |
| EX-31.1 - EX-31.1 - Ra Pharmaceuticals, Inc. | a2240828zex-31_1.htm |
| EX-23.1 - EX-23.1 - Ra Pharmaceuticals, Inc. | a2240828zex-23_1.htm |
| EX-4.3 - EX-4.3 - Ra Pharmaceuticals, Inc. | a2240828zex-4_3.htm |
QuickLinks -- Click here to rapidly navigate through this document
CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Annual Report on Form 10-K of Ra Pharmaceuticals, Inc. (the "Company") for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned hereby certifies, pursuant to 18 U.S.C. (section) 1350, as adopted pursuant to (section) 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated:
February 27, 2020
| /s/ DOUGLAS A. TRECO Douglas A. Treco, Ph.D. President and Chief Executive Officer (Principal Executive Officer) |
||
/s/ DAVID C. LUBNER David C. Lubner Executive Vice President and Chief Financial Officer (Principal Financial Officer) |
1
CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002